{"id":6417,"date":"2019-11-18T17:43:29","date_gmt":"2019-11-18T12:13:29","guid":{"rendered":"https:\/\/www.delveinsight.com\/blog\/?p=6417"},"modified":"2025-05-08T12:13:29","modified_gmt":"2025-05-08T06:43:29","slug":"complex-regional-pain-syndrome-treatment-therapies","status":"publish","type":"post","link":"https:\/\/www.delveinsight.com\/blog\/complex-regional-pain-syndrome-treatment-therapies","title":{"rendered":"Complex Regional Pain Syndrome Upcoming Therapies"},"content":{"rendered":"\n<p><strong> <\/strong>As per DelveInsight\u2019s estimates, total\nComplex Regional Pain Syndrome cases in the 7MM were found to be 253,603 in\n2017. The United States accounted for the highest CRPS prevalent population\nwith 179,441 cases.<\/p>\n\n\n\n<p>In terms of European countries, Germany recorded for the highest Complex regional pain syndrome prevalence with 18,459 cases, with the UK closely following behind with Spain dominating the least share of CRPS prevalent population. <\/p>\n\n\n\n<p><a href=\"https:\/\/www.delveinsight.com\/blog\/complex-regional-pain-syndrome-crps-a-debilitating-disease\/\"><strong>Complex regional pain syndrome <\/strong><\/a>(CRPS), is a rare neurologic condition which renders its sufferers in severe chronic pain. Lack of awareness and understanding of the condition leaves a CRPS patient pool vulnerable. <\/p>\n\n\n\n<p>At present, the Complex regional pain\nsyndrome treatment is restricted to palliative care. <\/p>\n\n\n\n<p><strong>Complex regional pain syndrome Therapy\nMarket<\/strong><\/p>\n\n\n\n<p>Therapies such as Bone resorption factor inhibitors, NMDA receptor antagonist, and Cannabinoid receptor agonists have the potential to increase the Complex regional pain syndrome market size. The CRPS upcoming therapies might help by optimizing the outcomes of patients with aggressive malignancy. <\/p>\n\n\n\n<p><strong><a href=\"https:\/\/www.delveinsight.com\/report-store\/complex-regional-pain-syndrome\">Complex regional pain syndrome therapies<\/a><\/strong> such as Neridronate (Abiogen Pharma\/Gr\u00fcnenthal), AXS-02 (Axsome Therapeutics), BHV-5000 (BioHeaven Pharmaceuticals), and PPP001 (Tetra Bio-Pharma), are expected to impact Complex regional pain syndrome treatment market positively. <\/p>\n\n\n\n<p><strong>Complex regional pain syndrome Pipeline <\/strong><\/p>\n\n\n\n<p>CRPS therapies such as Neridronate (Abiogen Pharma\/Gr\u00fcnenthal), AXS-02 (Axsome Therapeutics), BHV-5000 (BioHeaven Pharmaceuticals), and PPP001 (Tetra Bio-Pharma) are anticipated to impact Complex regional pain syndrome treatment market positively. <\/p>\n\n\n\n<p>Neridronate (Abiogen Pharma\/Gr\u00fcnenthal),\nthe first in class, non-opioid therapeutic, is under Phase III clinical trials which\nwill be administered intravenously. The chemical composition of the drug in the\nform of bisphosphonates have improved the condition in the patient pool. A\npotential bone resorption molecule can help in bone remodelling. <\/p>\n\n\n\n<p>Allotted the fast track designation,\nBreakthrough drug and Orphan drug designation, the drug is going to occupy the\nmajor chunk of Complex regional pain syndrome market share in the 7MM, once it\ngets approved in 2022. <\/p>\n\n\n\n<p>In addition to Neridronate, oral zoledronic acid will also take the Complex regional pain syndrome therapy market in the right direction opening doors to new approaches to treat Complex regional pain syndrome. <\/p>\n\n\n\n<p>The stake of Complex regional pain syndrome\ntreatment landscape lies on how readily and fast the Research and Development\nin the field takes place. A combination therapy of existing and upcoming CRPS\ndrugs may bring an efficient and standard Complex regional pain syndrome\ntreatment regime. <\/p>\n\n\n\n<p>Overall, the increasing awareness in this rare condition along with upcoming novel therapies will fuel the market during the forecast period, 2019-2028. <\/p>\n\n\n\n<div class=\"schema-faq wp-block-yoast-faq-block\"><div class=\"schema-faq-section\" id=\"faq-question-1574412873351\"><strong class=\"schema-faq-question\">What is Complex regional pain syndrome ?<\/strong> <p class=\"schema-faq-answer\"> Complex regional pain syndrome  is a rare neurologic condition which renders its sufferers in severe chronic pain.  <\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1574412932248\"><strong class=\"schema-faq-question\"> <br\/>What is the prevelant population of Complex regional pain syndrome in US?<\/strong> <p class=\"schema-faq-answer\"> The United States accounted for the highest CRPS prevalent population with 179,441 cases. <\/p> <\/div> <\/div>\n","protected":false},"excerpt":{"rendered":"<p>As per DelveInsight\u2019s estimates, total Complex Regional Pain Syndrome cases in the 7MM were found to be 253,603 in 2017. The United States accounted for the highest CRPS prevalent population with 179,441 cases. In terms of European countries, Germany recorded for the highest Complex regional pain syndrome prevalence with 18,459 cases, with the UK closely [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":6434,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[17],"tags":[2921,6939,17816,6938,903,623],"industry":[17225],"therapeutic_areas":[17245],"class_list":["post-6417","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articles","tag-complex-regional-pain-syndrome","tag-complex-regional-pain-syndrome-market","tag-complex-regional-pain-syndrome-pipeline","tag-complex-regional-pain-syndrome-upcoming-therapies","tag-gsk","tag-who","industry-pharmaceutical","therapeutic_areas-neurology"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v25.8 (Yoast SEO v25.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Complex Regional Pain Syndrome Pipeline | DelveInsight<\/title>\n<meta name=\"description\" content=\"In terms of European countries, Germany recorded for the highest Complex regional pain syndrome prevalence with 18,459 cases, with the UK closely...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.delveinsight.com\/blog\/complex-regional-pain-syndrome-treatment-therapies\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Complex Regional Pain Syndrome Pipeline | DelveInsight\" \/>\n<meta property=\"og:description\" content=\"In terms of European countries, Germany recorded for the highest Complex regional pain syndrome prevalence with 18,459 cases, with the UK closely...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.delveinsight.com\/blog\/complex-regional-pain-syndrome-treatment-therapies\" \/>\n<meta property=\"og:site_name\" content=\"DelveInsight Business Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/\" \/>\n<meta property=\"article:published_time\" content=\"2019-11-18T12:13:29+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-08T06:43:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/11\/04171318\/Complex-regional.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"772\" \/>\n\t<meta property=\"og:image:height\" content=\"482\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"DelveInsight\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:site\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"DelveInsight\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Complex Regional Pain Syndrome Pipeline | DelveInsight","description":"In terms of European countries, Germany recorded for the highest Complex regional pain syndrome prevalence with 18,459 cases, with the UK closely...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.delveinsight.com\/blog\/complex-regional-pain-syndrome-treatment-therapies","og_locale":"en_US","og_type":"article","og_title":"Complex Regional Pain Syndrome Pipeline | DelveInsight","og_description":"In terms of European countries, Germany recorded for the highest Complex regional pain syndrome prevalence with 18,459 cases, with the UK closely...","og_url":"https:\/\/www.delveinsight.com\/blog\/complex-regional-pain-syndrome-treatment-therapies","og_site_name":"DelveInsight Business Research","article_publisher":"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/","article_published_time":"2019-11-18T12:13:29+00:00","article_modified_time":"2025-05-08T06:43:29+00:00","og_image":[{"width":772,"height":482,"url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/11\/04171318\/Complex-regional.jpg","type":"image\/jpeg"}],"author":"DelveInsight","twitter_card":"summary_large_image","twitter_creator":"@DelveInsight","twitter_site":"@DelveInsight","twitter_misc":{"Written by":"DelveInsight","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":["WebPage","FAQPage"],"@id":"https:\/\/www.delveinsight.com\/blog\/complex-regional-pain-syndrome-treatment-therapies","url":"https:\/\/www.delveinsight.com\/blog\/complex-regional-pain-syndrome-treatment-therapies","name":"Complex Regional Pain Syndrome Pipeline | DelveInsight","isPartOf":{"@id":"https:\/\/www.delveinsight.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.delveinsight.com\/blog\/complex-regional-pain-syndrome-treatment-therapies#primaryimage"},"image":{"@id":"https:\/\/www.delveinsight.com\/blog\/complex-regional-pain-syndrome-treatment-therapies#primaryimage"},"thumbnailUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/11\/04171318\/Complex-regional.jpg","datePublished":"2019-11-18T12:13:29+00:00","dateModified":"2025-05-08T06:43:29+00:00","author":{"@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a"},"description":"In terms of European countries, Germany recorded for the highest Complex regional pain syndrome prevalence with 18,459 cases, with the UK closely...","mainEntity":[{"@id":"https:\/\/www.delveinsight.com\/blog\/complex-regional-pain-syndrome-treatment-therapies#faq-question-1574412873351"},{"@id":"https:\/\/www.delveinsight.com\/blog\/complex-regional-pain-syndrome-treatment-therapies#faq-question-1574412932248"}],"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.delveinsight.com\/blog\/complex-regional-pain-syndrome-treatment-therapies"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/complex-regional-pain-syndrome-treatment-therapies#primaryimage","url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/11\/04171318\/Complex-regional.jpg","contentUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/11\/04171318\/Complex-regional.jpg","width":772,"height":482,"caption":"Complex regional pain syndrome Upcoming Therapies"},{"@type":"WebSite","@id":"https:\/\/www.delveinsight.com\/blog\/#website","url":"https:\/\/www.delveinsight.com\/blog\/","name":"DelveInsight Business Research","description":"Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.delveinsight.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a","name":"DelveInsight","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","caption":"DelveInsight"}},{"@type":"Question","@id":"https:\/\/www.delveinsight.com\/blog\/complex-regional-pain-syndrome-treatment-therapies#faq-question-1574412873351","position":1,"url":"https:\/\/www.delveinsight.com\/blog\/complex-regional-pain-syndrome-treatment-therapies#faq-question-1574412873351","name":"What is Complex regional pain syndrome ?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":" Complex regional pain syndrome  is a rare neurologic condition which renders its sufferers in severe chronic pain.  ","inLanguage":"en-US"},"inLanguage":"en-US"},{"@type":"Question","@id":"https:\/\/www.delveinsight.com\/blog\/complex-regional-pain-syndrome-treatment-therapies#faq-question-1574412932248","position":2,"url":"https:\/\/www.delveinsight.com\/blog\/complex-regional-pain-syndrome-treatment-therapies#faq-question-1574412932248","name":"What is the prevelant population of Complex regional pain syndrome in US?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":" The United States accounted for the highest CRPS prevalent population with 179,441 cases. ","inLanguage":"en-US"},"inLanguage":"en-US"}]}},"author_meta":{"display_name":"DelveInsight","author_link":"https:\/\/www.delveinsight.com\/blog\/author\/gtadmin"},"featured_img":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/11\/04171318\/Complex-regional-300x187.jpg","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Articles<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Articles<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Complex regional pain syndrome<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">complex regional pain syndrome market<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Complex Regional Pain Syndrome Pipeline<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Complex regional pain syndrome Upcoming Therapies<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">GSK<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">WHO<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Complex regional pain syndrome<\/span>","<span class=\"advgb-post-tax-term\">complex regional pain syndrome market<\/span>","<span class=\"advgb-post-tax-term\">Complex Regional Pain Syndrome Pipeline<\/span>","<span class=\"advgb-post-tax-term\">Complex regional pain syndrome Upcoming Therapies<\/span>","<span class=\"advgb-post-tax-term\">GSK<\/span>","<span class=\"advgb-post-tax-term\">WHO<\/span>"]}},"comment_count":"1","relative_dates":{"created":"Posted 7 years ago","modified":"Updated 1 year ago"},"absolute_dates":{"created":"Posted on Nov 18, 2019","modified":"Updated on May 8, 2025"},"absolute_dates_time":{"created":"Posted on Nov 18, 2019 5:43 pm","modified":"Updated on May 8, 2025 12:13 pm"},"featured_img_caption":"Complex regional pain syndrome Upcoming Therapies ","series_order":"","_links":{"self":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/6417","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/comments?post=6417"}],"version-history":[{"count":1,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/6417\/revisions"}],"predecessor-version":[{"id":31917,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/6417\/revisions\/31917"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media\/6434"}],"wp:attachment":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media?parent=6417"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/categories?post=6417"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/tags?post=6417"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/industry?post=6417"},{"taxonomy":"therapeutic_areas","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/therapeutic_areas?post=6417"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}